[1] Ishino Y, Shinagawa H, Makino K, et al. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product[J]. J Bacteriol, 1987,169(12):5429-5433. [2] Jansen R, Embden J D, Gaastra W,et al. Identification of genes that areassociated with DNA repeats in prokaryotes[J].Mol Microbiol, 2002,43(6):1565-1575. [3] Barrangou R, Fremaux C, Deveau H, et al.CRISPR provides acquired resistance against viruses in prokaryotes[J]. Science,2007,315(5819):1709-1712. [4] Deltcheva E, Chylinski K, Sharma C M,et al.CRISPR RNA maturation by trans-encoded small RNA and host factorRNaseIII[J]. Nature,2011,471(7340):602-607. [5] Cong L, Ran F A, Cox D, et al.Multiplex genome engineering using CRISPR/Cas systems[J].Science,2013,339(6121):819-823. [6] 朱建勇. CRISPR/Cas系统在禽畜中的应用前景[J]. 畜牧与兽医,2015, 47(3): 133-135. [7] Makarova K S, Aravind L, Wolf Y I, et al. Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems[J]. Biol Direct, 2011,6:38. [8] Hille F, Richter H, Wong S P, et al. The biology of CRISPR-Cas: backward and forward[J].Cell, 2018,172(6):1239-1259. [9] Pyzocha N K, Ran F A, Hsu P D, et al. RNA-guided genome editing of mammalian cells[J]. Methods Mol Biol,2014,1114:269-277. [10]闫丽. 利用CRISPR/Cas9技术创制大豆GmWRI1a基因突变体[D]. 哈尔滨:东北农业大学, 2017. [11]Lu Y, Xue J, Deng T, et al. Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer[J].Nat Med,2020,26(5):732-740. |